◈ Nootpedia
Compact view
Research pass: thorough Peptide · Intranasal STRONG-CANDIDATE LOW

N-Acetyl Semax Amidate

Extended Research
◈ Extended Research ◈

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

▸ Our verdict STRONG-CANDIDATE LOW

Plausibly a longer-acting, more convenient Semax; mechanism extrapolated from parent compound; PK numbers and "3-5x potency" claims are vendor-marketing not peer-reviewed; only meaningful if vendor identity/COA can be verified — otherwise it's just expensive Semax (or worse, regular Semax mislabeled). Promote to higher confidence if a verified COA + 4-week self-trial replicates Semax effects at lower mcg with longer duration.

Research pass: thorough
▸ Decision matrix by user profile Per-archetype
  • Dylan20-30, brain-priority, high cognitive workload (Dylan-archetype)
    STRONG-CANDIDATE

    pending COA verification. If vendor identity verified, NASA is a quality-of-life win over regular Semax — once-daily dosing fits busy training+work schedule, lower mcg means longer per bottle. If COA can't be verified, Dylan should use regular Semax from CosmicNootropic (verified supply chain) instead. Adamax (already in V5 plan) covers a different mechanistic axis, so Adamax + NASA is the "both-and" stack rather than NASA replacing anything.

  • 30-50, executive maintenance
    S

    logic. NASA's longer duration suits busy professional schedules better than regular Semax's redose-every-4-hours pattern.

  • 50+, mild cognitive decline
    R

    Semax has more clinical evidence in elderly cognition (Russian trials). For this profile, stick with verifiable Semax until NASA accumulates real evidence. NASA is OPTIONAL-ADD here.

  • Anxiety-prone
    CAUTION

    Some users report mild stim-like activation. Selank (anxiolytic peptide) is a better default. NASA is OPTIONAL-ADD with careful titration.

  • High athletic load, tested status
    WADA

    does not list Semax or NASA on the prohibited list as of 2026, but peptides are a moving target. Tested athletes should verify current WADA list before use. Untested athletes (Dylan): no concern.

  • Sleep-disordered
    D

    AM only. Late dosing will disrupt sleep onset. NASA's longer duration is a feature in the day and a bug if dosed late.

  • Recovery-focused (post-injury, post-illness)
    P

    neurotrophic upside. Cerebrolysin remains the heavier-hitter for recovery cycles. NASA is OPTIONAL-ADD for daily maintenance.

  • Strength/anabolic-focused
    N

    relevant to this axis. NASA is brain-only. No HPG impact.

▸ Subjective experience (deep)

Per anecdote (consistent themes across multiple independent reports):

  • Onset: 2-15 minutes intranasal. Faster perceived onset than regular Semax for some users; comparable for others.
  • Peak: ~30-90 minutes in.
  • Strong window: ~3 hours of clearly noticeable effect.
  • Residual: Subtle drive / cognitive lift persists through the rest of the day from a single AM dose. This is the key practical difference from regular Semax, where most users feel a need to redose at 4-6 hours.
  • Character: "Cleaner" than Semax — less of a stimulant edge, more of a "thoughts arranging themselves" / "everything feels organized" quality. Reports of motivation, prioritization, working-memory ease, mild mood lift, reduced social anxiety, and improved verbal fluency. Not euphoric. Not jittery. Not appetite-suppressing.
  • Variability: Some users report needing higher doses than expected (the Tumblr post about 600 mcg "not working") — the response curve is NOT necessarily linear in regular-Semax mcg. Dose titration is required.
  • Comparison to regular Semax: Most users say they prefer NASA for daily use and reserve regular Semax for short bursts. Some say the difference is subtle.
▸ Tolerance + cycling deep dive
  • Tolerance buildup: Reported as minimal — most users say effects remain stable with consistent dosing. This matches the parent compound. However, the "BDNF burst" model implies that overstimulation may blunt response (analogous to receptor downregulation in monoaminergic systems), so cycling is prudent.
  • Recommended cycle: 4-6 weeks on, 1-2 weeks off. Some users run continuous; some run 30 days on / 30 days off (the conservative Russian protocol for regular Semax).
  • Reset protocol if needed: 2-week full break.
▸ Stacking deep dive

Synergistic with

  • adamax: Different mechanism (Adamax is dopamine-system focused via D2 modulation; NASA is BDNF/neurotrophin focused). Standard stacked protocol: Adamax 200 mcg intranasal + NASA 300 mcg intranasal AM. The Limitless Life "NASA / N-Acetyl Selank Amidate Blend" sold as a single spray is the commercial expression of the next obvious combo. For Dylan: Adamax + NASA AM is plausible as the V5 daily peptide stack.
  • selank: Anxiolytic peptide, complementary mechanism. NASA-AM + Selank-PRN is a classic combo for "default anxiolytic baseline + cognitive boost when needed." Selank is not consumed daily for Dylan in V5 (PRN tool), so this is co-administration when both are dosed.
  • cerebrolysin: Both are neurotrophic. Cerebrolysin cycles 2-4x/year would be the IM neurotrophic anchor; NASA daily is the cheap maintenance peptide between cycles. No known interactions.
  • bromantane: Different mechanism (bromantane is dopaminergic adaptogen with anti-asthenic effect). Stacks fine; commonly co-administered in Russian protocols.
  • modafinil: No known interaction. Modafinil = wakefulness/executive; NASA = neurotrophic + mood. Different pathways, additive subjective benefit reported in nootropic communities.

Avoid stacking with

  • semax (regular): Functional duplication. Same active peptide sequence, same downstream pathway, different PK. Stacking these is just paying twice for the same effect. Pick one.
  • n-acetyl semax (without amidate): Same logic — functional duplication. The single-modification N-acetyl Semax is itself superseded by NASA.
  • monoamine releasers (very high-dose amphetamine, MDMA-class): Theoretical risk of compounding monoamine elevation; no documented interaction but conservative call.
  • MAOIs: Theoretical (Semax has weak MAO-B effects). No documented interaction but worth flagging.

Neutral / safe co-administration

  • All V4 supplement-tier compounds (citicoline, omega-3s, magnesium, NAC, PS, theanine, rhodiola, creatine, B-vitamins, D3+K2)
  • Caffeine (no known interaction)
  • L-tyrosine, alpha-GPC, sulbutiamine, pramiracetam (V5 PRN tier)
▸ Drug interactions deep dive
  • CYP enzymes: Peptides are not generally CYP substrates; cleared via peptidase degradation. NASA's design specifically resists peptidases, so clearance is slower but mechanism is the same. No documented CYP induction/inhibition.
  • Contraceptives: No known interaction.
  • Anticoagulants: No documented interaction. Theoretical: BDNF/cerebral blood flow effects don't translate to bleeding risk based on Semax human data.
  • SSRIs/SNRIs: Co-administration appears safe in Russian clinical use of Semax. No specific NASA data.
▸ Pharmacogenomics
  • No specific pharmacogenomic data for NASA or Semax.
  • Theoretical considerations:
    • BDNF Val66Met polymorphism (rs6265) — Met carriers have lower activity-dependent BDNF secretion; NASA's effect may be blunted or different in Met/Met homozygotes. Worth checking on Dylan's 23andMe results in June 2026.
    • COMT Val158Met (rs4680) — Affects PFC dopamine clearance; might modulate the dopaminergic component of Semax-class peptides. Speculative.
    • MAO-B polymorphisms — Speculative relevance given Semax MAO-B inhibition reports.
▸ Sourcing deep dive
Path Vendor Cost Reliability Notes
Russian peptide retail (regular Semax) CosmicNootropic Semax 0.1% 3mL drops ~$30-40 / Semax 1% 3mL ~$50-70 High for Semax (real Russian Innovative Peptides Lab supply chain). They do not sell NASA as "N-Acetyl Semax Amidate" — only Adamax and regular Semax/Selank. This is what Dylan should buy if he wants the parent compound. Verifiable Russian pharma source.
Russian peptide retail RUPharma Similar to CosmicNootropic High for parent compound Same Russian supply chain; no NASA listed.
US research-chem Limitless Life Nootropics NASA 30 mg (10 mL spray, ~300 mcg/spray) ~$80-100 Medium — claims HPLC-MS, third-party tested COA. Verify COA per batch. One of the more reputable US research-chem vendors.
US research-chem Peptide Sciences NASA 30 mg ~$80 Medium — claims 99% purity, mass spec Mainstream RC vendor.
US research-chem NH Nootropics NASA 0.20% spray 20 mg/10 mL (240 mcg/spray) ~$60-80 Medium — listed on Amazon (notable for an RC peptide); claims COA Variable.
US research-chem PureRawz NASA, claims 99.9% pure Medium-Low — vendor reputation mixed Not first choice.
US research-chem BioLongevity Labs / Orovia / OROS / BioEdge / Ageless Humans NASA various Low to Medium Long-tail RC vendors. COA verification critical.
Avoid Everychem — Low Per Dylan's profile (vendor reputation issues).

Key sourcing reality for NASA: Unlike regular Semax (which has a real Russian pharmacy supply chain via Innovative Peptides Lab → CosmicNootropic / RUPharma), NASA is only sold by US research-chem vendors. There is no Russian-pharma-grade NASA. This means every NASA bottle is RC-supply-chain origin with all that implies — variable manufacturing, COA-claims-only quality control, and the realistic possibility that the bottle contains regular Semax, the wrong concentration, or degraded peptide.

COA verification is non-negotiable. Ask the vendor for the specific batch COA showing HPLC purity (>95%), mass spectrometry confirming molecular weight matches NASA (~855 Da, distinctly different from regular Semax at ~813 Da), and ideally sequencing confirmation. If a vendor refuses or hand-waves on this, walk away.

▸ Biomarkers to track (deep)
  • Baseline (before starting):
    • Subjective focus / motivation / mood baseline (1-10 daily log for 2 weeks pre-cycle)
    • Sleep onset and sleep quality baseline
    • Resting BP (peptide-adrenergic effects unlikely but documentable)
    • Plasma BDNF (exploratory only — assay variance is high; not actionable)
    • Bloodwork: CBC, CMP, lipids, hsCRP — already in Dylan's June 2026 panel
  • During use:
    • Daily subjective log (focus, motivation, mood, sleep, side effects) — this is the actual outcome measure
    • Weekly check on dose adequacy (titrate up if stagnant, down if jittery)
    • Bottle date opened (peptide degrades over weeks once reconstituted; refrigerate)
  • Post-cycle (if cycled):
    • 2-week wash subjective log to detect "did I really notice?" effect
    • No bloodwork needed for short-cycle use
▸ Controversies / open debates Live debate

  1. The half-life numbers vary wildly across sources. Vendor claims range from "30 min longer than Semax" (peptides.org) to "4-6 hours plasma half-life" (other vendors) to "8-12 hours" (older Reddit-derived encyclopedia entries) to "15-20% longer than regular Semax" (realpeptides.co). None of these are tied to a peer-reviewed PK study of NASA in humans. The honest answer: NASA is longer-lasting than regular Semax (which itself is "minutes" plasma half-life but hours of CNS effect via downstream BDNF signaling), but the exact numbers are unpublished. The previous encyclopedia entry (NOOTROPICS-ENCYCLOPEDIA-2026-05-05.md line 320) cited "8-12 hr half-life" — this is not well-sourced and should be treated as upper-bound speculation.

  2. The "3-5x potency" claim has no peer-reviewed basis. It's a vendor-marketing extrapolation from peptidase-resistance numbers, not from a dose-response comparison.

  3. D-Lys variant — As prompted, "N-Acetyl-(D-Lys)-Semax-Amidate" is a more aggressive modification. I could not find published evidence or vendor product corresponding to this specific structure. D-amino acid substitutions are a real peptide-stability strategy, but the naming in the prompt may conflate (a) the standard NASA structure, (b) a hypothetical D-amino-acid-modified NASA, or (c) some other peptide marketed under a similar name. If a vendor advertises a D-Lys variant specifically, that adds another layer of "what's actually in the bottle" risk.

  4. TBI mouse model claim — One source mentioned a 2023 BioRxiv preprint showing 50% lesion reduction in TBI mice. I could not locate this preprint in direct search and could not confirm the citation. Treat as unverified.

  5. Vendor-specific risk. Unlike CosmicNootropic regular Semax (real Russian pharma supply chain), every NASA product on the market is research-chem origin. Mods are easy to fake — a vendor could ship regular Semax and label it NASA without expert lab analysis catching it. This is the single biggest reason for LOW verdict-confidence.

  6. Russian researcher position vs Western nootropic community position. The original Russian Semax research focuses on stroke, optic atrophy, ADHD, and neuroprotection — clinical indications, not "longer-lasting daily nootropic." The whole framing of NASA as a daily cognitive enhancer is a Western nootropic-community elaboration. The Russians who developed Semax did not (publicly) push NASA as an upgrade for daily cognitive use.

▸ Verdict change log
  • 2026-05-05 — Initial verdict: STRONG-CANDIDATE / verdict-confidence LOW. Quality-of-life pick over regular Semax IF vendor identity/COA verifies. Otherwise default to verifiable CosmicNootropic regular Semax. Stack-pairing with Adamax is the most-defensible V5 daily peptide config; NASA does not replace Adamax (different mechanism) and should not be stacked with regular Semax (functional duplication).
▸ Open questions / gaps Open
  • Need: A real human PK study of NASA (plasma half-life, intranasal bioavailability, dose-response curve in healthy adults). None exists.
  • Need: Independent third-party COA testing of multiple NASA vendors to rank true purity/identity.
  • Need: Self-trial protocol — Dylan running NASA 200-300 mcg AM × 4 weeks with daily subjective log, vs a same-length regular-Semax cycle, to personally verify the duration / potency claim.
  • Need: Confirmation or refutation of the "D-Lys variant" naming. If it's real, source the published reference. If not, kill the term.
  • Need: Verify or kill the 2023 TBI mouse preprint claim.
  • Would change verdict: A reproducible 4-week self-trial showing clear duration advantage over regular Semax at lower mcg per dose → upgrade to STRONG-CANDIDATE / verdict-confidence MEDIUM. Vendor consolidation around a single clearly-COA-verifiable supplier → also upgrade. Conversely, an HPLC-MS test showing a popular NASA bottle contains regular Semax → drop to SKIP-FOR-NOW pending vendor reform.
▸ Sources (full, with our context)
Back to compact view